http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
PRWireNOW Expands Chinese Media Network with Addition of 100+ Leading Digital News Outlets
-
AOEP and Citiri Announce 2025 Opconic Awards Honoring Excellence in Operational Readiness and Owner Scope Management
-
Procyon Adds Bevin Nealon as Vice President, Strengthening Advisory Team in Connecticut
-
Kraken lists $KULA to advance Global impact investing
-
GivingTuesday Welcomes Amy Miller Taylor to Executive Leadership Team as Inaugural Chief Program Officer
-
AVVAA World Health Care Products, Inc. (OTC:AVVH)/GoldQuest Capital, Inc. Provides Shareholder Update
-
Golden Cariboo Resources Intersects 0.56 g/t Gold Over 99.84m (327.56 ft)
-
/U P D A T E -- Greenhouse Software, Inc./
-
Greenhouse Ranked Best ATS in the Overall, Enterprise, Mid-Market and EMEA Regional G2 Winter 2026 Reports
-
Receive SMS Announces Major Expansion of Global Virtual Number Platform
-
Hyundai Palisade Hybrid Wins Prestigious Car and Driver 10Best Trucks and SUVs Award
-
Sentient Jet Adds Cryptocurrency Payments, Continuing Its Legacy of Innovation
-
Sentient Jet Adds Cryptocurrency Payments, Continuing Its Legacy of Innovation
-
Leatt extends share buyback program through march 2026
-
Leatt Corp Announces Extension to the Share Repurchase Program
-
Graceland Celebrates Elvis’ Birthday with Five Days of Events This January
-
ImmunityBio's ANKTIVA shows 96% survival in bladder cancer study
-
Injectable Weightloss: Characteristics of GLP-1 Drugs and Food Demand
-
Grabien Announces Game-Changing Partnerships with WebKyte and FedNet
-
Cousins Maine Lobster Expands Across the Southeast with Three-Unit Deal in South Carolina and Alabama
-
From Legacy to AI-ready: Bison Transport Accelerates Its Digital Transformation with SnapLogic
-
New York Life Investments Expands Active ETF Lineup With Launch of NYLI MacKay Muni Allocation ETF (MMMA)
-
MetaComp and Stable Join Forces to Redefine Cross-Border Payments with Stablecoins
-
Bain Capital Completes Acquisition of Service Logic
-
ANKTIVA® with BCG Demonstrates 96% Survival from Bladder Cancer at Three Years with Median Survival Not Yet Reached in BCG-Unresponsive High-Grade Papillary-Only Non-Muscle Invasive Bladder Cancer
-
Worksport launches solar tonneau cover for Rivian R1T pickup truck
-
PolyPid names Brooke Story as board chairman
-
Ainos to Relocate U.S. Headquarters to Houston, Texas; Forms ScentAI Inc.
-
Worksport Launches Rivian R1T Pickup Truck Compatible Cover, SOLIS Solar Tonneau
-
Bayside Corporation Updates Website to Strengthen Investor Communication and Digital Focus
-
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors
-
Kyocera Selected as “Verizon Frontline Verified” Partner
-
THE LOCAL Credit Union Renews Partnership with Mahalo Banking to Advance Member-Centric Digital Services
-
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
-
Bragg Gaming Goes Live with Proprietary and Exclusive Content on Blaze in Brazil
-
Golden Matrix authorizes $3 million stock repurchase program
-
Golden Matrix Group, Inc. Announces Authorization of Stock Repurchase Program
-
Partnership With Native Americans Achieves Accreditation From BBB Wise Giving Alliance
-
Realbotix Announces Results of 2025 Annual Meeting
-
PharmaLogic Announces Successful Supply of First Cohort Dosing for Ratio Therapeutics' Phase 1/2 Study of a Novel FAP-Targeted Radiopharmaceutical in Late-Stage Aggressive Sarcomas
-
The Quaternary Group Ltd. Purchases a Further 2,843,600 Shares of Millennial Potash Corp
-
International Land Alliance Announces Closing To Acquire 300 Acres
-
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas
-
Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide
-
PRWireNOW Updates North American USA PR Distribution with Year-End Special Offer, as an Effective Press Release Distribution
-
DeFi Technologies' Valour gets Brazil approval for Solana ETP
-
Palvella Therapeutics receives FDA fast track designation for angiokeratoma treatment
-
Brixton Metals Reports the Balance of its 2025 Drill Results at the Trapper Gold Target
-
DeFi Technologies' Subsidiary Valour Approved to List Valour Solana (VSOL) ETP on Brazil's B3 Exchange
-
Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Angiokeratomas
